Us Congress 2025-2026 Regular Session

Us Congress House Bill HR699

Introduced
9/11/25  

Caption

Expressing support for the designation of September 2025 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

Impact

By designating a specific month to raise awareness, HR699 aims to foster understanding of the impact PKD has on individuals and their families. It stresses the need for better education about the disease since many individuals diagnosed may experience kidney failure by age 60, and public awareness can lead to improved health outcomes through early detection and appropriate medical care. The resolution implies a commitment at the federal level to prioritize kidney health initiatives.

Summary

HR699 expresses support for the designation of September 2025 as 'National Polycystic Kidney Disease Awareness Month'. This resolution aims to raise public awareness and understanding of polycystic kidney disease (PKD), a progressive genetic disorder affecting approximately 600,000 people in the United States. The resolution highlights the disease's impact on health and finances and advocates for increased public awareness to help improve treatment and care for affected individuals and their families.

Contention

While HR699 primarily serves as a means of raising awareness, it does not carry the legislative power to enact any changes to healthcare policy or funding. Thus, while it seeks to enhance understanding of PKD, the resolution may face criticism for lacking substance in terms of actual legislative change. The focus on awareness may be seen as insufficient by advocates who believe more concrete actions, such as funding for research and treatments, are necessary to address the significant health challenges posed by PKD.

Companion Bills

No companion bills found.

Previously Filed As

US HR1505

Expressing support for the designation of September 2024 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

US HR1384

Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September 2024 as "PCOS Awareness Month".

US HR678

Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September 2023 as "PCOS Awareness Month".

US HR1124

Expressing support for the designation of the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day".

US HR1511

Expressing support for the designation of September 2024 as "National Prostate Cancer Awareness Month".

US SR384

A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2023 as "PCOS Awareness Month".

US HR728

Expressing support for the designation of September 2023 as "Peripheral Artery Disease Awareness Month".

US HR1257

Expressing the need for enhanced public awareness of Huntington's Disease and support for the designation of a "National Huntington's Disease Awareness Month".

US HR700

Expressing support for the designation of September 2023 as "National Prostate Cancer Awareness Month".

US HR1264

Expressing support for the designation of May 2024 as "National Brain Tumor Awareness Month".

Similar Bills

US HR1505

Expressing support for the designation of September 2024 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

NH HB33

Relative to polycystic ovary syndrome awareness.

SC S0535

Declare September as PCOS Awareness Month

SC H4308

Declare September as PCOS Awareness Month

NC H749

Study Polycystic Ovary Syndrome

VA HB604

Health insurance; coverage for polycystic ovary syndrome.

IN SR0040

Recognizing the National Polycystic Ovary Syndrome Association's PCOS Challenge.

NJ A3366

Establishes Women's Menstrual Health Program to identify and assist patients with symptoms related to endometriosis and polycystic ovary syndrome.